Daily Archives: 19/11/2010

Hepatitis C Cont…(3)

(Post 1) (Post 2) (Post 3) Medivir is also developing Hepatitis C drug (TMC435) with Tibotec Pharmaceuticals. Medivir announced positive interim Phase IIb data on efficacy of TMC 435. (Bloomberg) TMC435 is a once daily protease inhibitor jointly developed by … Continue reading

Posted in Drug developments & targets | Leave a comment